- Home
- BCDA vs ZAPP Comparison
BCDA vs ZAPP Comparison
Compare BCDA & ZAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- ZAPP
- Stock Information
- Founded
- BCDA N/A
- ZAPP 2017
- Country
- BCDA United States
- ZAPP Thailand
- Employees
- BCDA N/A
- ZAPP 37
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- ZAPP Motor Vehicles
- Sector
- BCDA Health Care
- ZAPP Consumer Discretionary
- Exchange
- BCDA Nasdaq
- ZAPP Nasdaq
- Market Cap
- BCDA 7.9M
- ZAPP 7.6M
- IPO Year
- BCDA N/A
- ZAPP N/A
- Fundamental
- Price
- BCDA $1.85
- ZAPP $1.80
- Analyst Decision
- BCDA Strong Buy
- ZAPP
- Analyst Count
- BCDA 1
- ZAPP 0
- Target Price
- BCDA $25.00
- ZAPP N/A
- AVG Volume (30 Days)
- BCDA 61.9K
- ZAPP 90.0K
- Earning Date
- BCDA 11-13-2024
- ZAPP 11-29-2024
- Dividend Yield
- BCDA N/A
- ZAPP N/A
- EPS Growth
- BCDA N/A
- ZAPP N/A
- EPS
- BCDA N/A
- ZAPP N/A
- Revenue
- BCDA $71,000.00
- ZAPP N/A
- Revenue This Year
- BCDA $6.92
- ZAPP N/A
- Revenue Next Year
- BCDA N/A
- ZAPP $53,347.33
- P/E Ratio
- BCDA N/A
- ZAPP N/A
- Revenue Growth
- BCDA N/A
- ZAPP N/A
- 52 Week Low
- BCDA $1.84
- ZAPP $0.70
- 52 Week High
- BCDA $12.00
- ZAPP $19.10
- Technical
- Relative Strength Index (RSI)
- BCDA 29.98
- ZAPP 26.73
- Support Level
- BCDA $2.21
- ZAPP $1.62
- Resistance Level
- BCDA $2.47
- ZAPP $2.08
- Average True Range (ATR)
- BCDA 0.16
- ZAPP 0.20
- MACD
- BCDA -0.04
- ZAPP -0.00
- Stochastic Oscillator
- BCDA 1.30
- ZAPP 17.48
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About ZAPP Zapp Electric Vehicles Group Limited
Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories.